145,266 members

Skip to content. | Skip to navigation

Network navigation
 

7.3 Pharmacy First in Forth

Up to 7. Partnership working
December 20. 2018
Robert Varnam

Recent research confirms the value of pharmacy-led services for patients and GP practices, with 83% of consultations for UTI, impetigo and COPD exacerbation being handled without referring to the practice. Satisfaction was high from patients and professionals. A relatively low uptake (less than 1 patient per practice per week) acts as a reminder of the importance of effective signposting for new options that reduce pressure on practices. 

 

The paper is at https://www.cambridge.org/core/journals/primary-health-care-research-and-development/article/building-capacity-in-primary-care-the-implementation-of-a-novel-pharmacy-first-scheme-for-the-management-of-uti-impetigo-and-copd-exacerbation/081495A4B038588DD036C5BB92A14797

 

ABSTRACT 

Aim

This service aimed to improve patient access to treatment for urinary tract infections (UTI), impetigo and exacerbation of chronic obstructive pulmonary disease (COPD) and relieve pressure on general practice and out of hours services.

Background

In 2016, a service (Pharmacy First) was introduced in Forth Valley for the management of UTI, impetigo and exacerbation of COPD using patient group directions in community pharmacies. Trained pharmacists supplied a limited range of prescription medicines. Pathways for GP referral were defined. After 5 months of implementation, the service was evaluated.

Methods

A quantitative evaluation was undertaken. Feedback was sought from patients, GPs, pharmacists and GP reception staff, using structured questionnaires. Pharmacy records were used to assess referrals and pharmacy data summarised the number and type of consultations. Basic cost data was obtained from the Health Board.

Findings

In all, 75 pharmacies (of 76), and all 55 GP practices in the area, participated in the service. Over a 5-month period, 1189 cases were managed, the majority being for UTI (75.4%) followed by impetigo (15.2%), then COPD (9.3%). Of all cases, 77.9% were prescribed medication by the pharmacist, 9.1% were given advice only and 16.7% were referred to the GP. Independent clinical assessment of a random sample of 30 GP referrals considered all to be ‘appropriate’. Feedback was received from 69 pharmacists, 34 GPs, 54 reception staff and 73 patients. Patients were very satisfied with the service, most frequently citing the ‘quick and efficient’ access to treatment, and a ‘professional service’. Two thirds of GPs (67%) and 59% of reception staff found the service useful, mainly because it reduced pressure on GP appointments. A further cost benefit evaluation would allow objective assessment of the value of this service.

Powered by Ploneboard